Running Oak Capital LLC Has $15.60 Million Holdings in Icon Plc $ICLR

Key Points

• Running Oak Capital LLC has increased its stake in Icon Plc by 29.2%, now owning approximately 0.13% of the company, valued at about $15.60 million.
• Icon reported earnings of $3.26 per share for the last quarter, exceeding analysts' expectations, but its revenue decreased 4.8% year-over-year, totaling $2.02 billion.
• Analysts have mixed ratings for Icon, with the average rating being a "Moderate Buy" and a consensus price target of $217.33.

Running Oak Capital LLC lifted its stake in Icon Plc (NASDAQ:ICLR - Free Report) by 29.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 107,218 shares of the medical research company's stock after acquiring an additional 24,260 shares during the period. Running Oak Capital LLC owned approximately 0.13% of Icon worth $15,595,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. SVB Wealth LLC acquired a new stake in Icon in the 1st quarter worth $28,000. Ameritas Advisory Services LLC acquired a new stake in Icon during the second quarter worth about $48,000. NBC Securities Inc. acquired a new stake in Icon during the first quarter worth about $59,000. Bruce G. Allen Investments LLC increased its stake in Icon by 1,772.7% during the second quarter. Bruce G. Allen Investments LLC now owns 412 shares of the medical research company's stock valued at $60,000 after acquiring an additional 390 shares during the period. Finally, Greykasell Wealth Strategies Inc. acquired a new position in Icon in the 1st quarter valued at approximately $69,000. 95.61% of the stock is currently owned by institutional investors and hedge funds.

Icon Stock Up 0.5%

Shares of ICLR opened at $193.89 on Monday. The firm has a market capitalization of $15.66 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 2.88 and a beta of 1.23. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.29 and a current ratio of 1.29. The business's fifty day moving average price is $173.71 and its two-hundred day moving average price is $156.51. Icon Plc has a 52 week low of $125.10 and a 52 week high of $303.69.

Icon (NASDAQ:ICLR - Get Free Report) last released its earnings results on Wednesday, July 23rd. The medical research company reported $3.26 earnings per share for the quarter, topping analysts' consensus estimates of $3.18 by $0.08. Icon had a return on equity of 10.95% and a net margin of 9.82%.The company had revenue of $2.02 billion during the quarter, compared to the consensus estimate of $1.98 billion. During the same quarter in the previous year, the company posted $3.75 earnings per share. The firm's quarterly revenue was down 4.8% on a year-over-year basis. Icon has set its FY 2025 guidance at 13.000-14.000 EPS. On average, analysts predict that Icon Plc will post 13.38 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on ICLR. Jefferies Financial Group lowered Icon from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $220.00 to $175.00 in a report on Tuesday, September 9th. Cowen reissued a "hold" rating on shares of Icon in a report on Friday, September 12th. Robert W. Baird increased their price objective on shares of Icon from $222.00 to $224.00 and gave the company an "outperform" rating in a research note on Tuesday, September 2nd. Rothschild & Co Redburn upgraded shares of Icon from a "neutral" rating to a "buy" rating and lifted their target price for the company from $184.00 to $236.00 in a research report on Wednesday, September 3rd. Finally, Barclays increased their price target on shares of Icon from $180.00 to $190.00 and gave the stock an "equal weight" rating in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and nine have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $217.33.

About Icon

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.